Search research articles
Contact Us
Filters
Showing results (161-170 of 185) with videos related to
Page
of 19
Sort By:
The American Journal of Medicine
|
May 1, 1990
Toxoplasma gondii pneumonia in patients with the acquired immunodeficiency syndrome
E Oksenhendler, J Cadranel, C Sarfati, et al.
Lancet (London, England)
|
July 27, 1985
Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement
M Lariviere, P Vingtain, M Aziz, et al.
Journal of Clinical Microbiology
|
July 1, 1993
Detection of Toxoplasma gondii in venous blood from AIDS patients by polymerase chain reaction
J Dupouy-Camet, S L de Souza, C Maslo, et al.
The Journal of Infectious Diseases
|
January 1, 1993
Intestinal microsporidiosis in human immunodeficiency virus-infected patients with chronic unexplained diarrhea: prevalence and clinical and biologic features
J M Molina, C Sarfati, B Beauvais, et al.
The Journal of Infectious Diseases
|
May 21, 1998
Albendazole for treatment and prophylaxis of microsporidiosis due to Encephalitozoon intestinalis in patients with AIDS: a randomized double-blind controlled trial
J M Molina, C Chastang, J Goguel, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 6, 2004
Synthesis of new fluoroquinolones and evaluation of their in vitro activity on Toxoplasma gondii and Plasmodium spp
G Anquetin, M Rouquayrol, N Mahmoudi, et al.
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales
|
January 1, 1989
[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. I. A comparative double-blind study of 220 patients with onchocerciasis treated with a single oral dose of 100, 150 or 200 mcg/kg]
M Larivière, B Beauvais, M Aziz, et al.
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales
|
January 1, 1989
[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. III. The tolerance and efficacy of a single oral dose of 150 mcg/kg in children]
M Larivière, B Beauvais, M Aziz, et al.
Presse Medicale (Paris, France : 1983)
|
March 30, 1996
[Risk factors of the occurrence of cerebral toxoplasmosis in patients with HIV infection. Definition of indications of primary prevention. Proposals of the Toxoplasmosis and other protozoan infections Group. Coordinated action N.5 - 1996 February]
C Leport, P Ambroise-Thomas, C Bazin, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
June 13, 2009
Evaluation of a new 5'-nuclease real-time PCR assay targeting the Toxoplasma gondii AF146527 genomic repeat
J Menotti, Y J-F Garin, P Thulliez, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 185) with videos related to
Sort By:
Page
of 19
The American Journal of Medicine
|
May 1, 1990
Toxoplasma gondii pneumonia in patients with the acquired immunodeficiency syndrome
E Oksenhendler, J Cadranel, C Sarfati, et al.
Lancet (London, England)
|
July 27, 1985
Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement
M Lariviere, P Vingtain, M Aziz, et al.
Journal of Clinical Microbiology
|
July 1, 1993
Detection of Toxoplasma gondii in venous blood from AIDS patients by polymerase chain reaction
J Dupouy-Camet, S L de Souza, C Maslo, et al.
The Journal of Infectious Diseases
|
January 1, 1993
Intestinal microsporidiosis in human immunodeficiency virus-infected patients with chronic unexplained diarrhea: prevalence and clinical and biologic features
J M Molina, C Sarfati, B Beauvais, et al.
The Journal of Infectious Diseases
|
May 21, 1998
Albendazole for treatment and prophylaxis of microsporidiosis due to Encephalitozoon intestinalis in patients with AIDS: a randomized double-blind controlled trial
J M Molina, C Chastang, J Goguel, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 6, 2004
Synthesis of new fluoroquinolones and evaluation of their in vitro activity on Toxoplasma gondii and Plasmodium spp
G Anquetin, M Rouquayrol, N Mahmoudi, et al.
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales
|
January 1, 1989
[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. I. A comparative double-blind study of 220 patients with onchocerciasis treated with a single oral dose of 100, 150 or 200 mcg/kg]
M Larivière, B Beauvais, M Aziz, et al.
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales
|
January 1, 1989
[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. III. The tolerance and efficacy of a single oral dose of 150 mcg/kg in children]
M Larivière, B Beauvais, M Aziz, et al.
Presse Medicale (Paris, France : 1983)
|
March 30, 1996
[Risk factors of the occurrence of cerebral toxoplasmosis in patients with HIV infection. Definition of indications of primary prevention. Proposals of the Toxoplasmosis and other protozoan infections Group. Coordinated action N.5 - 1996 February]
C Leport, P Ambroise-Thomas, C Bazin, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
June 13, 2009
Evaluation of a new 5'-nuclease real-time PCR assay targeting the Toxoplasma gondii AF146527 genomic repeat
J Menotti, Y J-F Garin, P Thulliez, et al.
Page
of 19